Synapse - Hayley M Estrella

Hayley M Estrella

Research Focus

Former Employee. Medicine; Research Stdy Asst II

Recent additions – View all

HuMab-5B1 (MVT-5873), a mAb targeting sLe(a), in combination with first-line gemcitabine plus nab-paclitaxel (gem/nab-P) for patients with pancreatic cancer (PDAC) and other CA19-9 positive malignancies
Meeting Abstract

O'Reilly, E. M.; Borazanci, E. H.; Yu, K. H.; Varghese, A. M.; Estrella, H.; Kamins, D.; Melink, T.; Dorr, K.; Maffuid, P.; Gutheil, J.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save
Phase I dose escalation study of 177Lu-HuMab-5B1 (MVT-1075) in combination with MVT-5873 as radioimmunotherapy (RIT) in subjects with relapsed / refractory pancreatic cancer or other CA19-9+malignancies
Meeting Abstract

O'Reilly, E. A.; Lohrmann, C.; O'Donoghue, J. A.; Borazanci, E.; Estrella, H.; Teng, R.; Melink, T.; Dorr, K.; Kearns, C.; Peterson, M.; more...
Cancer Research (2018)

Fulltext@MSK | Save
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma
Journal Article

O'Reilly, E. M.; Lee, J. W.; Lowery, M. A.; Capanu, M.; Stadler, Z. K.; Moore, M. J.; Dhani, N.; Kindler, H. L.; Estrella, H.; Maynard, H.; more...
Cancer (2018)

Fulltext@MSK | Save

Co-authors at MSK

Types of Work

Publications